top of page

Testimonials

“Solange is great CFO, a great operator and a great strategist

 At several key points in Ionpath's journey, she provided insights that were transformative for our business and I often wonder where we would be without her advice and counsel.  She is the rare consultant who cared about my business's success just as much as the founding team and who was willing to work just as hard to drive results.  Should you be lucky enough to work with Solange, she will bring an extraordinary level of depth and breadth to your team and will do everything possible to ensure your success."


Harris Feinberg, CEO of Ionpath.

​

“At BlueBee we are a fast growing, highly scalable life sciences business. Solange joined us to team up with our CFO to help accelerate the setup of our global finance processes and more importantly so to support our fund-raising activities and investor relations. With her vast network in the financial world, investors and bankers, she made an impactful contribution by way of opening doors, supporting business plan development and board interactions. With her experience in several multi-national corporations, her flair in developing personal interactions with all stakeholders and her eye for detail, she has been a game-changer for BlueBee’s growth.”

​

Hans Cobben, CEO of BlueBee.

​

"We engaged with Marc Dentand for strategic financial advice. What was crucial for us was Marc’s ability to combine business insights from different sectors and integrate them into one aligned strategic plan that was ready to work with, agile and adaptable to changing environments. Marc’s honest and open approach, never avoiding the tough questions and discussions, was crucial in this process and made our collaboration a very successful journey."

​

Ingrid Brands MD PhD, CEO BioStrand

​

“From the day Solange walked into our lab she was part of the team. She took the time to really and truly understand our business, which had not been my experience with other external CFOs. She deeply understood the science and the potential of what we were building, and she didn't start working on the financial modeling until she really understood the people, the workflow, and the science. She is well versed in working with bio tech companies as well as working in earlier stage companies and has a great understanding of the uncertainty that can come with a company that is still figuring out aspects of product market fit. Her advice and understanding of what level of financial acumen we needed in the organization was invaluable, and before her engagement ended, she made sure that we had staff that covered our ongoing needs  She is smart, strategic and a valuable addition to any board meeting.”

 

Megan Klimen, COO of 3SCAN.

​

bottom of page